Status:

RECRUITING

Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis

Lead Sponsor:

Huashan Hospital

Conditions:

Myasthenia Gravis

Eligibility:

All Genders

18+ years

Brief Summary

This research is a single-center, exploratory, observational study to be carried out in the outpatient or inpatient ward of the Neurology Department at Huashan Hospital, affiliated to Fudan University...

Detailed Description

The goal is to define the multimodal digital phenotypes of myasthenia gravis patients, determine the specificities of their symptoms, and develop a digital evaluation model and remote assessment syste...

Eligibility Criteria

Inclusion

  • For Patients with MG
  • Patients have a confirmed diagnosis of myasthenia gravis and be over 18 years old.
  • Patients have the clinical classification of Myasthenia Gravis Foundation of America (MGFA) within I-IV, or be asymptomatic after treatment.
  • Patients must sign the informed consent form and the privacy confidentiality agreement.
  • For Healthy Participants
  • Age group matched with MG participants

Exclusion

  • For Patients with MG
  • Patients are in the crisis stage of myasthenia gravis (MGFA class V) and unable to cooperate with scoring.
  • Patients are with severe cardiopulmonary diseases and unable to cooperate with the scoring.
  • Patients with any psychiatric disorder or cognitive dysfunction that, in the investigator's judgment, may interfere with their participation in the study.
  • Patients with any other unspecified unstable medical condition.

Key Trial Info

Start Date :

August 31 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT07146425

Start Date

August 31 2023

End Date

December 1 2025

Last Update

August 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Huashan Hospital, affiliated to Fudan University

Shanghai, China